Send feedback

MACF1 p.Met4352Val

c.13054A>G · rs2296172 · VCV1232730

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.0592 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 21.3%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
1
lissencephaly 9 with complex brainstem malformation

Computational evidence

Protein change
AlphaMissense0.0592likely benign
REVEL0.084moderately benign-leaning
SaProt—not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAIΔ0.63donor gain · deltas
Constraint at this position
ConservationphyloP -0.032GERP -1.8
Regional constrainto/e 0.87unconstrained · MANE · 93 kb · p 4.8e-14 · regional, not allelic
Overall
CADD17.54PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM M4357V vs ClinVar M4352V) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 21.3% European (non-Finnish) · 251,797/1,179,466 alleles
Filtering AF 21.3% ClinGen BA1/BS1 input FAF95, joint · FAF99 21.2%
Overall 19.6% 316,993/1,613,338 alleles · common exomes 292,667/1,461,116 · genomes 24,326/152,222 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 23.4% 4
European (non-Finnish)grpmax 21.3% 5
Admixed American 20.9% 5
Finnishnot grpmax-eligible 19.8% 5
Remaining individualsnot grpmax-eligible 18.4% 5
East Asian 16.8% 6
Middle Eastern 15.9% 6
South Asian 11.2% 9
Amishnot grpmax-eligible 9.98% 10
African / African-American 3.68% 27

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MACF1
Protein
p.Met4352Val
Coding
c.13054A>G
MANE Select
NM_001394062
dbSNP
rs2296172
Type
single nucleotide variant
Location
chr1:39370145 (GRCh38)
Gene constraint
LOEUF 0.238 · pLI 1.00 (gnomAD)
Full MACF1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/macf1-p-met4352val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown